PharmaShots Weekly Snapshots (Feb 08 – 12, 2021)

 PharmaShots Weekly Snapshots (Feb 08 – 12, 2021)

Visby’s POC COVID-19 Test Receives the US FDA’s EUA for Use in CLIA Waived Settings

Published: Feb 12, 2020 | Tags: Visby, POC, COVID-19, Test, Receives, US, FDA, EUA, Use, CLIA, Waived, Settings

Takeda Collaborates with Ensoma to Accelerate Next-Generation In Vivo Gene Therapies

Published: Feb 12, 2020 | Tags: Takeda, Collaborates, Ensoma, Accelerate, Next-Generation, Vivo Gene Therapies

Roche Reports Results of Faricimab in Four P-III Studies for Diabetic Macular Edema and Age-Related Macular Degeneration

Published: Feb 12, 2020 | Tags: Roche, Reports, Results, Faricimab, Four, P-III, Studies, Diabetic, Macular Edema, Age-Related Macular Degeneration

Regeneron’s Evkeeza (evinacumab-dgnb) Receives the US FDA’s Approval for Patients with Homozygous Familial Hypercholesterolemia

Published: Feb 12, 2020 | Tags: Regeneron, Evkeeza (evinacumab-dgnb), Receives, US, FDA, Approval, Patients, Homozygous Familial Hypercholesterolemia

Novartis to Acquire GSK’s Cephalosporin Antibiotics Business

Published: Feb 12, 2020 | Tags: Novartis, Acquire, GSK, Cephalosporin, Antibiotics, Business

BMS Collaborates with Molecular Templates to Develop Engineered Toxin Body Therapies for Cancer

Published: Feb 12, 2020 | Tags: BMS, Collaborates, Molecular Templates, Develop, Engineered, Toxin, Body, Therapies, Cancer

Evotec Collaborates with Related Sciences for Drug Discovery and Development

Published: Feb 11, 2020 | Tags: Evotec, Collaborates, Related Sciences, Drug Discovery, Development

AstraZeneca Signs Letter of Intent with IDT Biologika to Boost COVID-19 Vaccine Manufacturing Capability in the EU

Published: Feb 11, 2020 | Tags: AstraZeneca, Signs, Letter, Intent, IDT Biologika, Boost, COVID-19 Vaccine, Manufacturing, Capability, EU

Sanofi Collaborates with i2O Therapeutics to Evaluate Oral i2O Therapeutics

Published: Feb 11, 2020 | Tags: Sanofi, Collaborates, i2O Therapeutics, Evaluate, Oral, i2O Therapeutics

AbbVie Signs a License Agreement with Caribou Biosciences for CAR-T Cell Therapies Published: Feb 11, 2020 | Tags: AbbVie, Signs, License Agreement, Caribou Biosciences, CAR-T Cell Therapies

Galapagos and Gilead Discontinue the P-III Trials of Ziritaxestat (GLPG1690) for Idiopathic Pulmonary Fibrosis

Published: Feb 11, 2020 | Tags: Galapagos, Gilead, Discontinue, P-III, Trials, Ziritaxestat (GLPG1690), Idiopathic Pulmonary Fibrosis

Kaia Health Offers a Complete Musculoskeletal Care Solution with Kaia Gateway and Premium Partners

Published: Feb 11, 2020 | Tags: Kaia Health, Offers, Complete, Musculoskeletal Care Solution, Kaia Gateway, Premium Partners

Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B

Published: Feb 10, 2020 | Tags: Lonza, Divest, Specialty, Ingredients, Business, Bain Capital, Cinven ,$4.7B

Vico’s VO659 Receives EC’s Orphan Drug Designation for Spinocerebellar Ataxia

Published: Feb 10, 2020 | Tags: Vico, VO659, Receives, EC, Orphan Drug Designation,  Spinocerebellar Ataxia

Lannett Expand its Partnership with HEC to Include Biosimilar Fast-Acting Insulin

Published: Feb 10, 2020 | Tags: Lannett, Expand, Partnership, HEC, Include, Biosimilar, Fast-Acting, Insulin

Eli Lilly and AbCellera’s Bamlanivimab (LY-CoV555) and Etesevimab (LY-CoV016) Receive the US FDA’s EUA for COVID-19

Published: Feb 10, 2020 | Tags: Eli Lilly, AbCellera, Bamlanivimab (LY-CoV555), Etesevimab (LY-CoV016), Receive, US, FDA, EUA, COVID-19

Regeneron and Sanofi’s Libtayo (cemiplimab-rwlc) Receives US FDA’s Approval for Patients with Advanced Basal Cell Carcinoma

Published: Feb 10, 2020 | Tags: Regeneron, Sanofi, Libtayo (cemiplimab-rwlc), Receives, US, FDA, Approval,  Patients, Advanced Basal Cell Carcinoma

Lee’s Pharma Socazolimab Receives NMPA’s Breakthrough Therapy Designation for Treatment of Recurrent or Metastatic Cervical Cancer

Published: Feb 10, 2020 | Tags: Lee’s Pharma, Socazolimab, Receives, NMPA, Breakthrough Therapy Designation, Treatment, Recurrent, Metastatic, Cervical Cancer
BMS Report Results of Opdivo (nivolumab) + Cabometyx (cabozantinib) in P-III CheckMate -9ER Trial for 1L Treatment of Advanced Renal Cell Carcinoma

Published: Feb 9, 2020 | Tags: BMS, Report, Results, Opdivo (nivolumab), Cabometyx (cabozantinib), P-III, CheckMate -9ER Trial, 1L, Treatment, Advanced Renal Cell Carcinoma

Medidata Launches Sensor Cloud to Connect Device and Wearables in Clinical Trials

Published: Feb 9, 2020 | Tags: Medidata, Launches, Sensor Cloud, Connect, Device, Wearables,  Clinical Trials

BMS’ Inrebic (fedratinib) Receives EC’s Approval for Patients with Newly Diagnosed and Previously Treated Myelofibrosis

Published: Feb 9, 2020 | Tags: BMS, Inrebic (fedratinib), Receives, EC, Approval, Patients, Newly Diagnosed, Previously, Treated, Myelofibrosis

Signifier’s eXciteOSA Receives US FDA’s Approval for the Treatment of Mild Obstructive Sleep Apnea and Snoring

Published: Feb 9, 2020 | Tags: Signifie, eXciteOSA, Receives, US, FDA, Approval, Treatment, Mild Obstructive, Sleep Apnea, Snoring

Hologic Collaborate with Google Cloud to Advance Screening in Cervical Cancer

Published: Feb 9, 2020 | Tags: Hologic, Collaborate, Google Cloud, Advance, Screening, Cervical Cancer

ViiV Healthcare’s Rukobia (fostemsavir) Receives Marketing Authorization for the Treatment of Adults with Multidrug-Resistant HIV

Published: Feb 9, 2020 | Tags: ViiV Healthcare, Rukobia (fostemsavir), Receives, Marketing Authorization, Treatment, Adults, Multidrug-Resistant HIV

Celltrion’s Regdanvimab (CT-P59) Receives Korean MFDS Conditional Marketing Authorization for COVID-19

Published: Feb 8, 2020 | Tags: Celltrion, Regdanvimab (CT-P59), Receives, Korean, MFDS, Conditional Marketing Authorization, COVID-19

AstraZeneca’s Imfinzi Fails to Meet its Primary Endpoints in P-III KESTREL Study

Published: Feb 8, 2020 | Tags: AstraZeneca, Imfinzi, Fails, Meet, Primary Endpoints, P-III, KESTREL ,Study

CureVac Collaborate with UK Government to Develop Vaccines Against SARS-CoV-2 variants

Published: Feb 8, 2020 | Tags: CureVac, Collaborate, UK, Government, Develop, Vaccines, Against, SARS-CoV-2 variants

Roche’s Elecsys GDF-15 Assay Receives the US FDA’s Breakthrough Device Designation as a CDX in Cancer Treatment

Published: Feb 8, 2020 | Tags: Roche, Elecsys, GDF-15, Assay, Receives, US, FDA, Breakthrough Device Designation, CDX, Cancer, Treatment

Daiichi Sankyo Signs an Outsourcing Agreement with AstraZeneca for COVID-19 Vaccine in Japan

Published: Feb 8, 2020 | Tags: Daiichi Sankyo, Signs, Outsourcing Agreement, AstraZeneca, COVID-19, Vaccine, Japan

BMS’ Breyanzi (lisocabtagene maraleucel) Receives the US FDA’s Approval for Adults With R/R Large-B-Cell Lymphoma

Published: Feb 8, 2020 | Tags: BMS, Breyanzi (lisocabtagene maraleucel), Receives, US, FDA, Approval, Adults, R/R Large-B-Cell Lymphoma

Related post: PharmaShots Weekly Snapshot (Feb 01-05, 2021)

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post